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Objectives Vulvovaginal candidiasis (VVC) is an inflammation of the
genital mucosa, which mainly affects the vulva and vagina. Candida
spp. are considered commensal fungus, however, when there is
imbalance in the microbiota or the host immune system is compro-
mised, these can become pathogenic. C. albicans is responsible for
most cases of VVC and is able of expressing mechanisms which allow
the colonization or infection in the host. These factors related yeasts,
including the growth of strains resistant to antifungal agents and vir-
ulence attributes (such as biofilm formation) are important in the
development of VVC. In this sense, the objective of this study was to
evaluate the in vitro biofilm formation and susceptibility to antifungal
of C. albicans isolates from patients with vulvovaginal candidiasis.
Methods For the study were analyzed 30 clinical isolates of Candida
albicans. The clinical isolates were separated in groups of 10 samples
of the according to symptoms presented by the patients: asymp-
tomatic (AS), vulvovaginal candidiasis (VVC) and recurrent vulvo-
vaginal candidiasis (RVVC). For all isolates were analyzed biofilm
formation and minimal inhibitory concentration (MIC) for flucona-
zole and nystatin. The MIC was performed according to M27-A3 pro-
tocol of the Clinical Laboratory Standards Institute. Biofilm forming
ability was assessed through quantification of total biomass by crys-
tal violet (CV) staining, performed on 96-well microplates containing
a cellular suspension of 1 9 107 cells ml1 and incubated for 24 h
at 37°C.
Results Antifungal susceptibility testing is showed in table 1. The
isolates were tested to the two antifungals. The MIC raging from
0.125 to 2 lg ml1 for fluconazole and 1 to 4 lg ml1 to nystatin.
The figure 1 show the quantification of the total biomass. It was evi-
dent that all the C. albicans isolates were able to form biofilm,
although differences occurred depending on the isolated and conse-
quently the group. Importantly it was noted that, in general, VVC
and RVVC groups had similar capacity biofilm formation. On the
other hand, these groups had less total biomass (average
Abs = 1,091  0.88) compared with AS group (average Abs =
1,521  1.32).
Conclusion Although all the samples analyzed are sensitive to anti-
fungals tested research of resistant strains is relevant, since recur-
rences are related to cases of VVC. Nystatin and fluconazole were
effective in small concentrations for the isolates analysed. All samples
were able to form biofilm and the average of the group of asymp-
tomatic patients greater than the others. Thus, the capacity to form-
ing biofilm is an important virulence factor in the persistence of
microorganisms in infectious processes and represent an increase in
resistance to antifungal and host defense.
Table 1. Range of MIC and MIC50, MIC90 of 30 clinical isolates of
patients with VVC front of the antifungal fluconazole and nystatin.
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